These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 2515880
21. Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Dournon E, Matheron S, Rozenbaum W, Gharakhanian S, Michon C, Girard PM, Perronne C, Salmon D, De Truchis P, Leport C. Lancet; 1988 Dec 03; 2(8623):1297-302. PubMed ID: 2904016 [Abstract] [Full Text] [Related]
22. Efficacy of zidovudine treatment in homosexual men with AIDS-related complex: factors influencing development of AIDS, survival and drug intolerance. Australian Zidovudine Study Group. Swanson CE, Tindall B, Cooper DA. AIDS; 1994 May 03; 8(5):625-34. PubMed ID: 8060543 [Abstract] [Full Text] [Related]
23. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh T. Am Rev Respir Dis; 1992 Aug 03; 146(2):285-9. PubMed ID: 1362634 [Abstract] [Full Text] [Related]
24. Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC. Bessen LJ, Greene JB, Louie E, Seitzman P, Weinberg H. N Engl J Med; 1988 Mar 17; 318(11):708. PubMed ID: 3422706 [No Abstract] [Full Text] [Related]
25. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. Spector SA, Gelber RD, McGrath N, Wara D, Barzilai A, Abrams E, Bryson YJ, Dankner WM, Livingston RA, Connor EM. N Engl J Med; 1994 Nov 03; 331(18):1181-7. PubMed ID: 7935655 [Abstract] [Full Text] [Related]
26. Response of serum p24 antigen and antibody to p24 antigen in patients with AIDS and AIDS-related complex treated with zidovudine. Williams IG, Gabriel G, Kelly G, Loveday C, Tedder RS, Weller IV. AIDS; 1990 Sep 03; 4(9):909-12. PubMed ID: 2123627 [Abstract] [Full Text] [Related]
27. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. Schmitt FA, Bigley JW, McKinnis R, Logue PE, Evans RW, Drucker JL. N Engl J Med; 1988 Dec 15; 319(24):1573-8. PubMed ID: 3059187 [Abstract] [Full Text] [Related]
28. Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex. Glaser JB, Volpe S, Aguirre A, Simpkins H, Schiffman G. J Infect Dis; 1991 Oct 15; 164(4):761-4. PubMed ID: 1894937 [Abstract] [Full Text] [Related]
29. Efficacy of granulocyte colony-stimulating factor (G-CSF) on neutropenia in zidovudine-treated patients with AIDS and ARC: a preliminary report. Garavelli PL. Haematologica; 1992 Oct 15; 77(3):293-4. PubMed ID: 1385275 [No Abstract] [Full Text] [Related]
30. Zidovudine overdose: a case with bone-marrow toxicity. Lafeuillade A, Poizot-Martin I, Dhiver C, Bouabdallah R, Quilichini R, Gastaut JA. AIDS; 1991 Jan 15; 5(1):116-7. PubMed ID: 2059355 [No Abstract] [Full Text] [Related]
31. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee. Lancet; 1994 Apr 09; 343(8902):871-81. PubMed ID: 7908356 [Abstract] [Full Text] [Related]
32. The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudine. Jacobson MA, De Gruttola V, Reddy M, Arduino JM, Strickland S, Reichman RC, Bartlett JA, Phair JP, Hirsch MS, Collier AC. AIDS; 1995 Jul 09; 9(7):727-34. PubMed ID: 7546418 [Abstract] [Full Text] [Related]
33. [Long-term success with zidovudine in HIV infection]. Leber Magen Darm; 1989 May 09; 19(3):158. PubMed ID: 2500573 [No Abstract] [Full Text] [Related]
34. Didanosine therapy in patients intolerant of or failing zidovudine therapy. Rathbun RC, Martin ES. Ann Pharmacother; 1992 Nov 09; 26(11):1347-51. PubMed ID: 1362093 [Abstract] [Full Text] [Related]
35. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study. Stambuk D, Youle M, Hawkins D, Farthing C, Shanson D, Farmer R, Lawrence A, Gazzard B. Q J Med; 1989 Feb 09; 70(262):161-74. PubMed ID: 2512592 [Abstract] [Full Text] [Related]
36. Zidovudine--the first year of experience. Williams I, Gabriel G, Cohen H, Williams P, Tedder RS, Machin S, Weller IV. J Infect; 1989 Jan 09; 18 Suppl 1():23-31. PubMed ID: 2915140 [No Abstract] [Full Text] [Related]
37. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine. Jacobson MA, Bacchetti P, Kolokathis A, Chaisson RE, Szabo S, Polsky B, Valainis GT, Mildvan D, Abrams D, Wilber J. BMJ; 1991 Jan 12; 302(6768):73-8. PubMed ID: 1671651 [Abstract] [Full Text] [Related]
38. [Treatment of HIV infection with zidovudine. The good use of AZT]. Régnier B. Rev Prat; 1991 Sep 01; 41(19):1801-4. PubMed ID: 1925359 [No Abstract] [Full Text] [Related]
39. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: long-term experience. Smiley L. J Infect; 1989 Jan 01; 18 Suppl 1():77. PubMed ID: 2644363 [No Abstract] [Full Text] [Related]
40. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. Volberding PA, Lagakos SW, Koch MA, Pettinelli C, Myers MW, Booth DK, Balfour HH, Reichman RC, Bartlett JA, Hirsch MS. N Engl J Med; 1990 Apr 05; 322(14):941-9. PubMed ID: 1969115 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]